Interleukin - 17 and Interleukin-10 As Inflammatory and Prevention Biomarkers in Periimplant Diseases

Overview

Journal Int J Prev Med

Date 2019 Sep 14

PMID 31516678

Citations 7

Authors

Shirin Zahra Farhad

Faeze Rezazadeh

Majid Mohammadi

Affiliations

Soon will be listed here.

Abstract

Background: Periimplant diseases are inflammatory diseases. Thus, the level of preinflammatory cytokines which has important role in the inflammation processes can consider as biomchemical markers for early diagnosis and prevention of periimplant diseases. The aim of this study was to determine and compare the level of interleukin (IL)-17 and IL-10 in patients with periimplant mucositis and periimplantitis.

Methods: This case--control study was conducted on 51 patients with implants which were loaded at least 1 year previously, 17 patients with periimplant mucositis, 17 patients with periimplantitis, and 17 individuals with healthy implants. After clinical examination, gingival crevicular fluid sampling was carried out by paper point number 25 for 4 min and the mean value of IL-17, IL-10 in samples was measured using enzyme linked immunosorbent assay (ELISA), least square differences (LSD) reader in laboratory. The data was analyzed using statistical software SPSS 22. Quantitative analysis was done using One-way analysis of variance (ANOVA) test and LSD past test.

Results: The results of analysis showed that there was a significant difference in the mean value of IL-17 and IL-10 between the three study groups ( < 0.001). Individuals with healthy implants showed a significant lower level of IL-17 than patients with periimplantitis ( = 0.001) and for patients with periimplantitis, the level of IL-17 was significantly lower than that of patients with periimplant mucositis ( < 0.001) and IL-10 level was significantly lower in mucositis than periimplantitis ( < 0.001).

Conclusions: The level of IL-17 and IL-10 increased in patients with periimplant compared to individuals with healthy periimplant tissues and the results showed that the highest concentrations of IL-17 and IL-10 were observed in patients with periimplant mucositis and periimplantitis, respectively.

Citing Articles

Experimental peri-implantitis induces neuroinflammation: An exploratory study in rats.

Cafferata E, Ramanauskaite A, Cuypers A, Obreja K, Dohle E, Ghanaati S BMC Oral Health. 2024; 24(1):1238.

PMID: 39425138 PMC: 11490110. DOI: 10.1186/s12903-024-04995-z.

Evaluation of the effect of adjunctive diode laser application on peri-implant crevicular fluid biomarker levels: a randomized controlled trial.

Erduran N, Guncu G, Akman A, Acar B, Pinar A, Karabulut E Clin Oral Investig. 2024; 28(8):459.

PMID: 39080143 PMC: 11289239. DOI: 10.1007/s00784-024-05855-4.

Oral Fluid Biomarkers for Peri-Implantitis: A Scoping Review.

Lumbikananda S, Srithanyarat S, Mattheos N, Osathanon T Int Dent J. 2023; 74(3):387-402.

PMID: 38065782 PMC: 11123564. DOI: 10.1016/j.identj.2023.11.005.

Current Molecular, Cellular and Genetic Aspects of Peri-Implantitis Disease: A Narrative Review.

Chmielewski M, Pilloni A Dent J (Basel). 2023; 11(5).

PMID: 37232785 PMC: 10217441. DOI: 10.3390/dj11050134.

The diagnostic utility of IL-10, IL-17, and PCT in patients with sepsis infection.

Zhang W, Wang W, Hou W, Jiang C, Hu J, Sun L Front Public Health. 2022; 10:923457.

PMID: 35937269 PMC: 9355284. DOI: 10.3389/fpubh.2022.923457.

References

Oda T, Yoshie H, Yamazaki K . Porphyromonas gingivalis antigen preferentially stimulates T cells to express IL-17 but not receptor activator of NF-kappaB ligand in vitro. Oral Microbiol Immunol. 2003; 18(1):30-6. DOI: 10.1034/j.1399-302x.2003.180105.x. View

Troen B . Molecular mechanisms underlying osteoclast formation and activation. Exp Gerontol. 2003; 38(6):605-14. DOI: 10.1016/s0531-5565(03)00069-x. View

Johnson R, Wood N, Serio F . Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol. 2004; 75(1):37-43. DOI: 10.1902/jop.2004.75.1.37. View

Kelly M, Kolls J, Happel K, Schwartzman J, Schwarzenberger P, Combe C . Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun. 2004; 73(1):617-21. PMC: 538931. DOI: 10.1128/IAI.73.1.617-621.2005. View

Yu J, Gaffen S . Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci. 2007; 13:170-7. DOI: 10.2741/2667. View

Andreiotelli M, Koutayas S, Madianos P, Strub J . Relationship between interleukin-1 genotype and peri-implantitis: a literature review. Quintessence Int. 2008; 39(4):289-98. View

Severino V, Napimoga M, Pereira S . Expression of IL-6, IL-10, IL-17 and IL-8 in the peri-implant crevicular fluid of patients with peri-implantitis. Arch Oral Biol. 2011; 56(8):823-8. DOI: 10.1016/j.archoralbio.2011.01.006. View

Iyer S, Cheng G . Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012; 32(1):23-63. PMC: 3410706. DOI: 10.1615/critrevimmunol.v32.i1.30. View

Fonseca F, Moraes Junior M, Lourenco E, Teles D, Figueredo C . Cytokines expression in saliva and peri-implant crevicular fluid of patients with peri-implant disease. Clin Oral Implants Res. 2012; 25(2):e68-72. DOI: 10.1111/clr.12052. View

10.

Khammissa R, Feller L, Meyerov R, Lemmer J . Peri-implant mucositis and peri-implantitis: clinical and histopathological characteristics and treatment. SADJ. 2012; 67(3):122, 124-6. View

11.

Kadkhodazadeh M, Baghani Z, Ebadian A, Youssefi N, Mehdizadeh A, Azimi N . IL-17 gene polymorphism is associated with chronic periodontitis and peri-implantitis in Iranian patients: a cross-sectional study. Immunol Invest. 2013; 42(2):156-63. DOI: 10.3109/08820139.2012.746697. View

12.

Darabi E, Kadkhoda Z, Amirzargar A . Comparison of the levels of tumor necrosis factor-α and interleukin-17 in gingival crevicular fluid of patients with peri-implantitis and a control group with healthy implants. Iran J Allergy Asthma Immunol. 2013; 12(1):75-80. DOI: 012.01/ijaai.7580. View

13.

Casado P, Canullo L, de Almeida Filardy A, Granjeiro J, Porto Barboza E, Duarte M . Interleukins 1β and 10 expressions in the periimplant crevicular fluid from patients with untreated periimplant disease. Implant Dent. 2013; 22(2):143-50. DOI: 10.1097/ID.0b013e3182818792. View

14.

. Peri-implant mucositis and peri-implantitis: a current understanding of their diagnoses and clinical implications. J Periodontol. 2013; 84(4):436-43. DOI: 10.1902/jop.2013.134001. View

15.

Belibasakis G . Microbiological and immuno-pathological aspects of peri-implant diseases. Arch Oral Biol. 2013; 59(1):66-72. DOI: 10.1016/j.archoralbio.2013.09.013. View

16.

Araujo M, Filho A, da Silva G, de Melo M, Napimoga M, Rodrigues D . Evaluation of peri-implant mucosa: clinical, histopathological and immunological aspects. Arch Oral Biol. 2014; 59(5):470-8. DOI: 10.1016/j.archoralbio.2014.01.011. View

17.

Cheng W, Hughes F, Taams L . The presence, function and regulation of IL-17 and Th17 cells in periodontitis. J Clin Periodontol. 2014; 41(6):541-9. DOI: 10.1111/jcpe.12238. View

18.

Purvis H, Anderson A, Young D, Isaacs J, Hilkens C . A negative feedback loop mediated by STAT3 limits human Th17 responses. J Immunol. 2014; 193(3):1142-50. DOI: 10.4049/jimmunol.1302467. View

19.

Recker E, Avila-Ortiz G, Fischer C, Pagan-Rivera K, Brogden K, Dawson D . A cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients. J Periodontol. 2014; 86(2):264-72. PMC: 4394381. DOI: 10.1902/jop.2014.140354. View

20.

Chitrapriya M, Ranga Rao S, Lavu V . Interleukin-17 and interleukin-18 levels in different stages of inflammatory periodontal disease. J Indian Soc Periodontol. 2015; 19(1):14-7. PMC: 4365148. DOI: 10.4103/0972-124X.145798. View